C
West Pharmaceutical Services, Inc. WST
$230.11 $6.382.85%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 492.70M 499.60M 524.90M 568.70M 593.40M
Total Depreciation and Amortization 155.40M 150.60M 146.10M 141.30M 137.30M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 2.40M 45.90M 50.20M 54.80M 66.20M
Change in Net Operating Assets 2.90M 6.30M 31.20M -8.20M -20.40M
Cash from Operations 653.40M 702.40M 752.40M 756.60M 776.50M
Capital Expenditure -377.00M -380.80M -395.30M -370.50M -362.00M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -1.70M -1.90M -1.00M -6.70M -6.70M
Cash from Investing -378.70M -382.70M -396.30M -377.20M -368.70M
Total Debt Issued 164.70M 164.70M 35.00M -- --
Total Debt Repaid -192.30M -192.90M -60.30M -2.40M -2.40M
Issuance of Common Stock 32.70M 32.70M 47.10M 52.50M 51.00M
Repurchase of Common Stock -566.60M -689.10M -664.80M -652.00M -451.20M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -59.10M -58.60M -58.10M -57.60M -57.00M
Other Financing Activities -2.00M 0.00 0.00 -100.00K --
Cash from Financing -622.60M -743.20M -701.10M -659.60M -459.60M
Foreign Exchange rate Adjustments -21.40M 15.80M -5.10M -4.30M 11.40M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -369.30M -407.70M -350.10M -284.50M -40.40M
Weiss Ratings